LIFE SCIENCES RESEARCH PARTNERS VZW
Patent Owner
Stats
- 21 US PATENTS IN FORCE
- 4 US APPLICATIONS PENDING
- Feb 22, 2018 most recent publication
Details
- 21 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 589 Total Citation Count
- Dec 22, 1987 Earliest Filing
- 30 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2016/0158,231 PYRIMIDINE HYDROXY AMIDE COMPOUNDS FOR TREATING PERIPHERAL NEUROPATHYDec 04, 15Jun 09, 16[A61K]
2015/0045,369 NOVEL MARKERS FOR DETECTING MICROSATELLITE INSTABILITY IN CANCER AND DETERMINING SYNTHETIC LETHALITY WITH INHIBITION OF THE DNA BASE EXCISION REPAIR PATHWAYOct 03, 14Feb 12, 15[C12Q]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9862777 Single domain antibodies against SOD1 and their use in medicineMay 28, 14Jan 09, 18[A61K, C07K]
9617548 Liver-specific nucleic acid regulatory elements and methods and use thereofApr 21, 09Apr 11, 17[C07H, A61K, C12N, C07K]
9353164 Cardiac-specific nucleic acid regulatory elements and methods and use thereofOct 29, 10May 31, 16[A61K, C12N, C07K]
9234025 Extracellular allosteric inhibitor binding domain from a tyrosine kinase receptorJul 02, 10Jan 12, 16[G01N, C07K]
8741862 PHD2 inhibition for blood vessel normalization, and uses thereofJan 20, 10Jun 03, 14[A61K, C12N]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2016/0193,192 EXTRACELLULAR ALLOSTERIC INHIBITOR BINDING DOMAIN FROM A TYROSINE KINASE RECEPTORAbandonedNov 30, 15Jul 07, 16[A61K]
2016/0166,532 CARNITINE PALMITOYLTRANSFERASE 1 INHIBITORS FOR INHIBITION OF PATHOLOGICAL ANGIOGENESISAbandonedJul 25, 14Jun 16, 16[A61K, C12N]
2014/0294,811 METHOD FOR PREDICTING RISK OF HYPERTENSION ASSOCIATED WITH ANTI-ANGIOGENESIS THERAPYAbandonedFeb 26, 14Oct 02, 14[A61K, C12Q]
2013/0227,717 HDAC INHIBITORS TO TREAT CHARCOT-MARIE-TOOTH DISEASEAbandonedOct 06, 11Aug 29, 13[A61K, A01K]
2013/0177,564 ADMINISTERING ANTI-PLACENTAL GROWTH FACTOR ANTIBODIESAbandonedMar 05, 13Jul 11, 13[A61K]
2013/0177,565 ADMINISTERING ANTI-PLACENTAL GROWTH FACTOR ANTIBODIESAbandonedMar 05, 13Jul 11, 13[A61K]
2013/0078,224 INDUCTION/MONITORING OF ARTERIOGENESIS USING SDF1 AND PDGFB OR INHIBITION OF PHD2AbandonedMar 30, 11Mar 28, 13[A61K]
2012/0263,710 ADMINISTERING ANTI-PLACENTAL GROWTH FACTOR ANTIBODIESAbandonedMay 14, 12Oct 18, 12[A61K, A61P, C07K]
2012/0195,858 RESPONSIVENESS TO ANGIOGENESIS INHIBITORSAbandonedAug 03, 10Aug 02, 12[A61K, C07H, C12Q, A61P]
2012/0009,678 IMMUNOTHERAPY TARGETING INTRACELLULAR PATHOGENSAbandonedFeb 16, 09Jan 12, 12[C12N, C07K]
8003096 Means and methods for the recruitment and identification of stem cellsExpiredMar 28, 06Aug 23, 11[A61K]
2011/0010,786 TRANSGENIC ANIMAL EXPRESSING B CELL ANTIGEN RECEPTORAbandonedJul 09, 10Jan 13, 11[C12N, A01K]
7858089 Antibodies binding to the A2 domain of FVIII and inhibiting coagulation activityExpiredJul 31, 06Dec 28, 10[A61K]
7858593 Inhibitors of prolyl-hydroxylase-1 for the treatment of skeletal muscle degenerationExpiredJul 11, 08Dec 28, 10[A01N]
2010/0178,297 Means and methods for the recruitment and identification of stem cellsAbandonedJul 01, 09Jul 15, 10[A61K, A61P]
2010/0129,372 INHIBITION OF PACAP SIGNALLING FOR THE PREVENTION AND TREATMENT OF THROMBOCYTOPENIAAbandonedAug 31, 09May 27, 10[A61K, A61P]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.